Another factor that induces the endothelial dysfunction in MetS patients is the insulin, which, in physiological conditions, could exert a vasodilator action; in fact, insulin acts on the phosphorylation of endothelial nitric oxide synthase (eNOS) which causes the nitric oxide (NO) increase, able to induce vasodilation. The gene discussed is NOS3; the disease is metabolic syndrome.